Detalles de la búsqueda
1.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol
; 98(1): 112-121, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266607
2.
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
Eur J Haematol
; 106(5): 708-715, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33580608
3.
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working party.
Am J Hematol
; 94(1): 80-86, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30328134
4.
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 24(5): 930-936, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29339268
5.
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Haematologica
; 103(3): 514-521, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29217776
6.
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP.
Bone Marrow Transplant
; 57(6): 896-902, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352038
7.
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
J Clin Med
; 11(12)2022 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35743620
8.
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT.
Leukemia
; 35(12): 3551-3560, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023851
9.
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study.
Clin Lymphoma Myeloma Leuk
; 21(10): 686-693, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158265
10.
Discrepancies in the management of Clostridioides difficile infections in patients after allogeneic haematopoietic cell transplantation: the results of the Infectious Diseases Working Party EBMT survey.
Bone Marrow Transplant
; 57(4): 685-687, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35145219
Resultados
1 -
10
de 10
1
Próxima >
>>